Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Mínguez A, Conde I, Montón C, Gonzalez L, Pascual S, Antón MD, Palau A, Forés A, Gisbert C, Ojeda A, Girona E, Di Maira T, Berenguer M. Mínguez A, et al. Among authors: monton c. Dig Dis Sci. 2024 May;69(5):1863-1871. doi: 10.1007/s10620-024-08368-y. Epub 2024 Mar 22. Dig Dis Sci. 2024. PMID: 38517562
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.
Perelló C, Carrión JA, Ruiz-Antorán B, Crespo J, Turnes J, Llaneras J, Lens S, Delgado M, García-Samaniego J, García-Paredes F, Fernández I, Morillas RM, Rincón D, Porres JC, Prieto M, Lázaro Ríos M, Fernández-Rodríguez C, Hermo JA, Rodríguez M, Herrero JI, Ruiz P, Fernández JR, Macías M, Pascasio JM, Moreno JM, Serra MÁ, Arenas J, Real Y, Jorquera F, Calleja JL; Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Acting Drugs. Perelló C, et al. J Viral Hepat. 2017 Mar;24(3):226-237. doi: 10.1111/jvh.12637. Epub 2016 Dec 15. J Viral Hepat. 2017. PMID: 27976491
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado D, Fernández-Patón M, Alfaro-Cervello C, Mestre-Alagarda C, Bauza M, Gallen-Peris A, Merino V, Benlloch S, Pérez-Rojas J, Ferrández A, Puglia V, Gimeno-Torres M, Aguilera V, Monton C, Escudero-García D, Alberich-Bayarri Á, Serra MA, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Biomolecules. 2021 Dec 2;11(12):1808. doi: 10.3390/biom11121808. Biomolecules. 2021. PMID: 34944452 Free PMC article.
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease.
Marti-Aguado D, Rodríguez-Ortega A, Mestre-Alagarda C, Bauza M, Valero-Pérez E, Alfaro-Cervello C, Benlloch S, Pérez-Rojas J, Ferrández A, Alemany-Monraval P, Escudero-García D, Monton C, Aguilera V, Alberich-Bayarri Á, Serra MÁ, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Aliment Pharmacol Ther. 2021 Jan;53(1):160-171. doi: 10.1111/apt.16100. Epub 2020 Sep 27. Aliment Pharmacol Ther. 2021. PMID: 32981113
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score.
Marti-Aguado D, Arnouk J, Liang JX, Lara-Romero C, Behari J, Furlan A, Jimenez-Pastor A, Ten-Esteve A, Alfaro-Cervello C, Bauza M, Gallen-Peris A, Gimeno-Torres M, Merino-Murgui V, Perez-Girbes A, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández-Izquierdo A, Aguilera V, Giesteira B, França M, Monton C, Escudero-García D, Alberich-Bayarri Á, Serra MA, Bataller R, Romero-Gomez M, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Liver Int. 2024 Jan;44(1):202-213. doi: 10.1111/liv.15766. Epub 2023 Oct 30. Liver Int. 2024. PMID: 37904633
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D, Ten-Esteve A, Baracaldo-Silva CM, Crespo A, Coello E, Merino-Murgui V, Fernandez-Paton M, Alfaro-Cervello C, Sánchez-Martín A, Bauza M, Jimenez-Pastor A, Perez-Girbes A, Benlloch S, Pérez-Rojas J, Puglia V, Ferrández A, Aguilera V, Latorre M, Monton C, Escudero-García D, Bosch-Roig I, Alberich-Bayarri Á, Marti-Bonmati L. Marti-Aguado D, et al. Among authors: monton c. Front Endocrinol (Lausanne). 2023 Aug 3;14:1213441. doi: 10.3389/fendo.2023.1213441. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600695 Free PMC article.
Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.
Ballester MP, Gallego JJ, Fiorillo A, Casanova-Ferrer F, Giménez-Garzó C, Escudero-García D, Tosca J, Ríos MP, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-Miguel T, Kosenko E, Serra MÁ, Felipo V, Montoliu C. Ballester MP, et al. Among authors: monton c. Sci Rep. 2022 Feb 14;12(1):2463. doi: 10.1038/s41598-022-06416-z. Sci Rep. 2022. PMID: 35165326 Free PMC article.
Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor.
Ballester MP, Abril C, Merino V, Alós M, Segarra G, Tosca J, Montón C, Casasus N, Lluch P. Ballester MP, et al. Among authors: monton c. Cancer Diagn Progn. 2024 Sep 1;4(5):623-630. doi: 10.21873/cdp.10373. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238615 Free PMC article.
123 results